A Phase II Study of Imetelstat (GRN163L, NSC# 754228) in Children With Relapsed or Refractory Solid Tumors.
Phase of Trial: Phase II
Latest Information Update: 14 Feb 2017
At a glance
- Drugs Imetelstat (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 07 Mar 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to suspended.
- 30 Jan 2014 According to the ClinicalTrials.gov record, planned initiation date changed from 1 Dec 2013 to 1 Jan 2014.
- 18 Dec 2013 New trial record